Smith W C
Department of Ophthalmology, University of Florida, Gainesville 32610-0284, USA.
Exp Eye Res. 1996 Jun;62(6):585-92. doi: 10.1006/exer.1996.0069.
Retinal arrestin is known to participate in the quenching of phototransduction through binding to light-activated and phosphorylated rhodopsin. Recently, a splice variant of retinal arrestin was identified in bovine photoreceptors which could bind unphosphorylated photoactive rhodopsin. In this report, a splice variant of retinal arrestin is identified in the human retina. The variant of human arrestin is produced by splicing out exon 12, unlike the bovine variant which is produced by splicing out exon 16. This 78 bp deletion in the human splice variant produces a polypeptide with a calculated molecular weight of 42.2 kDa that lacks 26 amino acids when compared to the full-length retinal arrestin. The use of quantitative competitive PCR indicates that the mRNA for the human splice variant of arrestin is present at approximately one-twentieth of the level of human arrestin mRNA.
视网膜抑制蛋白已知可通过与光激活和磷酸化的视紫红质结合来参与光转导的淬灭。最近,在牛的光感受器中鉴定出一种视网膜抑制蛋白的剪接变体,它可以结合未磷酸化的光活性视紫红质。在本报告中,在人类视网膜中鉴定出一种视网膜抑制蛋白的剪接变体。人类抑制蛋白的变体是通过剪接掉外显子12产生的,这与通过剪接掉外显子16产生的牛变体不同。人类剪接变体中的这种78 bp缺失产生了一种计算分子量为42.2 kDa的多肽,与全长视网膜抑制蛋白相比,该多肽缺少26个氨基酸。定量竞争性PCR的结果表明,人类抑制蛋白剪接变体的mRNA水平约为人类抑制蛋白mRNA水平的二十分之一。